Aldara™ Cream, 5% (Imiquimod)


Aldara Cream, 5% (Imiquimod)







  • No contraindications
  • Pregnancy category B
  • Rare systemic side effects have not been shown to be a concern with this drug.
  • Mainly seen:
    • Erythema
    • Edema
    • Induration
    • Vesiculation
    • Excoriation
    • Scaling and flaking
  • Administration of this cream is not recommended until the skin is completely healed from any previous drug or surgical treatment.
  • Aldara™ cream has the potential to exacerbate inflammatory conditions of the skin.
  • Exposure to sunlight (including sunlamps) should be avoided or minimized during use of Aldara™ Cream because of concern for heightened sunburn susceptibility. Patients should be warned to wear protective clothing when out in the sun.
  • Patients with sunburn should be advised not to use Aldrara™ cream until fully recovered.
  • Patients who may have considerable sun exposure, e.g., due to their occupation, and those patients with inherent sensitivity to sunlight should exercise caution when using this cream. Phototoxicity has not been adequately assessed.

Next:   Cost of Treatment